Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(14%)
Results Posted
200%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_4
3
43%
Ph phase_3
1
14%
Ph phase_2
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(1)
Terminated(2)
Other(1)

Detailed Status

Not yet recruiting2
Completed1
Terminated1
Recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (28.6%)
Phase 31 (14.3%)
Phase 43 (42.9%)
N/A1 (14.3%)

Trials by Status

completed114%
not_yet_recruiting229%
terminated114%
recruiting114%
unknown114%
withdrawn114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7